• Cell Surface GlycoRNA–RBP Domains Enable Peptide Entry Pathw

  2026-05-28

  This study reveals that cell surface RNA-binding proteins (RBPs) and glycoRNAs form distinct nanoclusters, which serve as entry sites for cell-penetrating peptides like TAT. These findings expand our understanding of membrane organization and suggest new strategies for probing cell surface interactions and targeted delivery.

• Expanding Biomedical Discovery with the DiscoveryProbe™ FDA-

  2026-05-28

  Explore how the DiscoveryProbe FDA-approved Drug Library (SKU: L1021) accelerates high-throughput assay development and advanced pharmacological target identification. This article uniquely connects state-of-the-art metabolomics extraction with practical assay optimization for translational research.

• In Vitro Activity of Sisomicin vs. Tobramycin and Related Am

  2026-05-27

  This article examines a seminal study comparing the in vitro antibacterial activity of sisomicin to established aminoglycoside antibiotics, including tobramycin and gentamicin, across a range of clinical isolates. The findings clarify relative potencies, reveal key resistance patterns, and provide a rigorous methodological benchmark for antibiotic efficacy testing in Gram-negative and Gram-positive pathogens.

• Notch Inhibition Boosts Immunotherapy in Triple-Negative Bre

  2026-05-27

  This study demonstrates that suppressing Notch signaling enhances the effectiveness of immune checkpoint blockade in triple-negative breast cancer by remodeling the tumor immune microenvironment. The findings suggest a synergistic approach that may overcome immunotherapy resistance and reduce metastatic spread.

• Biotin-HPDP for Thiol-Specific Protein Labeling: Protocols &

  2026-05-26

  Biotin-HPDP enables selective, reversible thiol labeling—empowering workflows in redox biology, affinity purification, and S-nitrosylation detection. This guide details optimal protocols, troubleshooting, and real-world innovations for maximizing its impact in neurodegeneration and protein modification research.

• Muscle-Derived BDNF Directs Early Postsynaptic NMJ Assembly

  2026-05-26

  This study demonstrates that muscle-generated BDNF, regulated by localized release and proteolytic processing, orchestrates the initial formation of postsynaptic acetylcholine receptor clusters at vertebrate neuromuscular junctions. The findings clarify the spatial and enzymatic mechanisms underlying synaptic assembly, with implications for understanding neuromuscular development and potential intervention points.

• Sulfo-NHS-SS-Biotin: Advanced Cell Surface Protein Labeling

  2026-05-25

  Sulfo-NHS-SS-Biotin Kit redefines cell surface and protein labeling, enabling reversible, amine-specific biotinylation for high-resolution interactome studies. Its water-soluble, disulfide-cleavable design streamlines workflows from glycoRNA-RBP nanocluster analysis to robust purification, surpassing traditional biotinylation reagents.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-25

  This study systematically characterizes the prevalence, genetic context, and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) isolated from hospitals in Guangdong Province during 2022–2024. The findings reveal dominant gene types, high rates of horizontal gene transfer, and critical epidemiological trends, offering actionable insight for antimicrobial resistance research and infection control strategies.

• Oxaliplatin in Chemoresistance: Dissecting Molecular Pathway

  2026-05-24

  Explore how Oxaliplatin, a platinum-based chemotherapeutic agent, disrupts tumor DNA and how new research on signaling pathways is reshaping resistance strategies. This article offers a unique, mechanistically focused perspective for advanced cancer research.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Surfac

  2026-05-23

  Sulfo-NHS-Biotin empowers researchers with highly selective, water-soluble biotinylation for cell surface protein analysis, minimizing background and maximizing reproducibility. Its membrane-impermeant chemistry streamlines workflows for affinity capture and interaction studies—setting a new standard in cell and molecular biology.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Studie

  2026-05-22

  Sulfo-NHS-Biotin enables selective, water-soluble biotinylation of cell surface proteins, streamlining advanced affinity and immunoprecipitation workflows. Learn how to optimize protocols, troubleshoot common issues, and leverage new research advances for robust, high-yield protein labeling.

• (+)-Bicuculline: Technical Guidance for GABAA Antagonist Use

  2026-05-22

  (+)-Bicuculline is a classical tool for antagonizing GABAA receptors, utilized to dissect inhibitory neurotransmission and modulate synaptic NMDA signaling in neuroscience research. It is not intended for diagnostic or clinical applications, and its use requires strict attention to solubility, storage, and workflow handling to ensure experimental reliability.

• Translational Leverage of γ-Glu-Cys in Glutathione Pathway E

  2026-05-21

  This thought-leadership article explores gamma-Glu-Cys (γ-Glu-Cys) as a critical mechanistic tool for advanced glutathione metabolism research, peptide engineering, and plant stress adaptation studies. Blending new mechanistic insights with strategic recommendations, it contextualizes APExBIO’s high-purity γ-Glu-Cys within the evolving landscape of microbial and plant biotechnology. The piece synthesizes recent evidence on Bacillus-mediated γ-glutamyl peptide production, evaluates protocol optimization, and forecasts translational opportunities, offering actionable guidance for researchers seeking to harness substrate-driven innovation beyond conventional protocols.

• (Z)-4-Hydroxytamoxifen: Applied Protocols for ER Modulation

  2026-05-21

  (Z)-4-Hydroxytamoxifen enables precise estrogen receptor modulation in preclinical breast cancer models, outperforming tamoxifen in selectivity and antiestrogenic potency. This article translates cutting-edge bench research into actionable workflows and troubleshooting strategies for maximizing experimental clarity and reproducibility.

• Low-Dose Decitabine Restores Immune Tolerance in ITP via Tre

  2026-05-20

  This study demonstrates that low-dose Decitabine (5-Aza-2'-deoxycytidine) rebalances T-cell subsets and restores immune tolerance in immune thrombocytopenia (ITP) by promoting regulatory T cell (Treg) function and suppressing proinflammatory Th1/Th17 cells. These findings highlight a new mechanistic rationale for using hypomethylating agents in autoimmune disease beyond their established roles in cancer epigenetics.

16760 records 1/1118 page Next 12345 下5页 Last page